SCHEMBL217854

SCHEMBL217854

Clc1ncc(Br)c(Cl)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25247012 0.79
SCHEMBL10034998 0.75
SCHEMBL31586523 0.75
SCHEMBL31259503 0.75
SCHEMBL4145389 0.75
SCHEMBL246368 0.75
SCHEMBL14594131 0.75
SCHEMBL13202779 0.75
SCHEMBL10161873 0.75
SCHEMBL2183234 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2841 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119751461-A PKMYT1 inhibitor and preparation method and application thereof 中国药科大学 2025-04-04 CN claimed
CN-119504740-A New preparation method of palbociclin 江苏权正检验检测有限公司 2025-02-25 CN claimed
CN-119059982-A Hydroxamic acid Mer/HDAC double-target inhibitor and preparation method and application thereof 河北科技大学 2024-12-03 CN claimed
CN-118724825-A Mer/HDAC double-target inhibitor and application thereof in preparation of antitumor drugs 河北科技大学 2024-10-01 CN claimed
CN-118027006-A 2, 4-Diaminopyrimidine derivative and preparation method and application thereof 温州医科大学附属第一医院 2024-05-14 CN claimed
CN-117903147-A Preparation method of treasipril and intermediate thereof 沈阳药科大学 2024-04-19 CN claimed
CN-117069663-B Synthesis method of rebaudinib intermediate V and synthesis method of rebaudinib 四川维亚本苑生物科技有限公司 2023-12-26 CN claimed
CN-117069663-A Synthesis method of rebaudinib intermediate V and synthesis method of rebaudinib 四川维亚本苑生物科技有限公司 2023-11-17 CN claimed
US-20230295144-A1 2-polysubstituted aromatic ring-pyrimidine derivatives, preparation and medical application thereof UNIV ZHEJIANG (CN) 2023-09-21 US claimed
CN-112920182-B Preparation method of palbociclib 上海天慈国际药业有限公司 2023-08-01 CN claimed
US-10822327-B2 2-substituted aromatic ring-pyrimidine derivative and preparation and application thereof ZHEJIANG UNIVERSITY (CN) 2020-11-03 US claimed
CN-111233834-A FAK-targeting compound and markers thereof, and preparation methods and applications of FAK-targeting compound and markers 北京师范大学 2020-06-05 CN claimed
EP-3530657-A1 2-POLYSUBSTITUTED AROMATIC RING-PYRIMIDINE DERIVATIVE AND PREPARATION AND MEDICAL USE Zhejiang University (CN) 2019-08-28 EP claimed
EP-3530656-A1 2-SUBSTITUTED AROMATIC RING-PYRIMIDINE DERIVATIVE, AND PREPARATION AND APPLICATION THEREOF Zhejiang University (CN) 2019-08-28 EP claimed
CN-109721547-A A kind of preparation method of intermediate that treating breast cancer medicines Pa Boxini 陈欣 2019-05-07 CN claimed
CN-109206375-A A kind of 5 cyclosubstituted 2,4- diaminopyrimidines with benzene glycinol class formation, its preparation and purposes 中国科学院上海药物研究所 2019-01-15 CN claimed
US-7825128-B2 Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs BAYER SCHERING PHARMA AG (DE) 2010-11-02 US claimed
EP-1963282-A1 SULFOXIMINE-SUBSTITUTED PYRIMIDINES , THEIR PREPARATION AND USE AS DRUGS Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 EP claimed
US-20070232632-A1 Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs BAYER INTELLECTUAL PROPERTY GMBH (DE) 2007-10-04 US claimed
WO-2007071455-A1 SULFOXIMINE-SUBSTITUTED PYRIMIDINES , THEIR PREPARATION AND USE AS DRUGS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-06-28 WO claimed